AYM Syntex Limited Overview
AYM Syntex is a mid-sized, promoter-controlled Indian manufacturer of synthetic filament yarns — polyester, nylon and polypropylene — with a deliberate tilt toward specialty, dyed and engineered products rather than commodity partially-oriented or fully-drawn yarn. Its distinguishing franchise is Bulk Continuous Filament (BCF) yarn for carpets and floor coverings, a niche in which CARE Ratings has long described it as India's leader, complemented by nylon textile yarns, dope-dyed and package-dyed polyester, sewing threads and industrial yarns. Operating from manufacturing complexes in Silvassa (Dadra & Nagar Haveli) and Palghar (Maharashtra), the company generated ₹1,365 cr of consolidated revenue in FY2026 with roughly 43% from exports to markets including the US, EU, UK and Australia. A Mandawewala-family company carved out of the former Welspun group, AYM combines scale-light, value-added positioning with thin net margins, moderate leverage, and an ongoing reverse merger of its holding company that will simplify the ownership structure.
What the company does
AYM Syntex manufactures and sells synthetic filament yarns used across apparel, home textiles, floor coverings (carpets and rugs), technical/industrial textiles and sewing threads. Simply Wall St's company description summarises the activity as manufacturing and selling polyester filament, nylon filament and BCF yarns for the textile and floor-covering industries in India, Australia, the European Union, New Zealand, the United Kingdom and the United States. The company itself (per its exchange-filing descriptor and Screener's AI summary) describes itself as a "manufacturer and exporter of Polyester Filament Yarn, Nylon Filament Yarn and Bulk Continuous Filament Yarn," and Trendlyne's profile characterises it as a specialist in polyester, nylon and polypropylene yarns focused on niche, value-added products rather than standard commodities. Third-party filing indexes note an R&D emphasis on customised yarn solutions with functional properties such as UV resistance, flame retardancy and antimicrobial performance.
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue model | ~100% product sales (manufactured yarn). No material service, subscription or licensing revenue disclosed |
| Product vs. service mix | Product ≈100%; minor other operating income (export incentives, scrap) not separately disclosed in sources reviewed |
| Pricing basis | Cost-plus/spread over crude-linked raw materials (PTA/MEG/polyester chips for PFY; caprolactam/nylon-6 chips for nylon; polypropylene) with premiums for colour, functionality and customisation |
| Value-chain position | Mid-stream converter: buys polymer chips (and in some cases POY), spins/draws/texturises/twists/dyes and sells yarn to weavers, knitters, carpet tufters, thread makers and technical-textile converters. Not backward-integrated into polymerisation (unlike Reliance, Filatex, Indo Rama) |
| Customer types | Domestic weavers/knitters, carpet and rug manufacturers (domestic and export), global carpet mills, sewing-thread companies, technical-textile converters |
| Customer concentration | Low — no single customer >10% of revenue (CARE Ratings, Mar 2026) |
| Geographic mix | Exports 43% of FY2025 turnover (CARE); 44% in FY2022 (CARE, Oct 2022) |
| Working-capital intensity | Working-capital cycle of 37 days in FY2025 (CARE), but heavy reliance on working-capital bank lines (short-term facilities rated: ₹385 cr) |
End-markets served
-
Floor coverings (BCF nylon and polyester/PP BCF for tufted carpets, rugs, automotive and contract flooring) — the company's differentiated franchise and largest export driver.
-
Apparel and fashion (textured/dyed polyester and nylon yarns for woven and knitted fabrics, intimate wear, sportswear, hosiery).
-
Home textiles (upholstery, furnishing fabrics, curtains).
-
Sewing threads (sewing thread line commissioned during the FY2019 expansion per CARE).
-
Technical/industrial textiles (industrial yarns, functional/engineered yarns — FR, UV-resistant, antimicrobial).
Independent characterisation
AYM is best understood as a specialty spread business operating in a commodity-dominated industry. Its sales line (₹1,350–1,500 cr across FY2022–FY2026) is small relative to integrated polyester majors, and it lacks polymer integration, so its gross margin depends on (a) raw-material spreads that swing with crude oil, PTA/MEG and caprolactam prices, and (b) its ability to sell colour- and function-differentiated yarns at premiums. EBITDA margins have oscillated between 6.8% and ₹35–43 cr) absorb most of EBITDA, leaving net margins of 0.1%–3.4%. The investment case therefore hinges on mix upgrades (BCF, IDY, dyed and specialty yarns), operating leverage from capacity utilisation, export demand (especially the US carpet market), and the post-merger capital structure.11% over five years, while depreciation (₹60 cr) and interest (
Strategy
Stated strategic themes
Based on filings, rating rationales and the preferential-issue objects, AYM's strategy rests on five themes: (1) shifting mix from commodity to value-added yarns (BCF, IDY, dyed, functional); (2) capacity expansion in higher-margin lines (₹100 cr IDY and BCF expansion); (3) deleveraging and working-capital efficiency (preferential issue proceeds for debt repayment and working capital); (4) export market development, notably the US (Innovative Yarns LLC); (5) corporate simplification (amalgamation of Mandawewala Enterprises). The company tagline in filings is "The Strength Within."
Initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Preferential equity issue | Oct 2024 | ₹141.76 cr at ₹182.50; objects: debt repayment ₹24 cr, working capital ₹25 cr, capex ₹59 cr, GCP ₹33.76 cr | Fully utilised by Dec 2025, no deviation |
| IDY & BCF capacity expansion | FY2025–FY2026 | Total project cost ₹100 cr, ₹59 cr funded by preferential issue; ₹21.05 cr capex in Q2 FY2026 alone | Funding fully deployed; commissioning status not disclosed |
| Amalgamation of Mandawewala Enterprises | Feb 2025 → ongoing | Simplify structure, enhance efficiency, reduce compliance costs | Shareholder & creditor approvals 25 May 2026; NCLT final sanction pending |
| US subsidiary | Sep 2025 | Innovative Yarns LLC, Delaware, 100% owned, yarn trading | Incorporated |
| ESOP programmes | Ongoing | AYM ESOP Scheme 2018 and 2021; allotments May 2025, Nov 2025, Mar 2026, Jun 2026, Jul 2026 | Active |
| Tariff recovery | FY2026–FY2027 | India Ratings expects recovery of ~₹25 cr additional tariffs incurred after US reciprocal tariffs | Pending |
| Renewable energy | FY2021 onward | 850 kWp solar at Silvassa | Operational; further targets not disclosed |
Medium-term targets / guidance
AYM does not publish formal financial guidance or medium-term targets. India Ratings (2026) expects FY2027 performance to improve on higher-margin products lifting revenue and EBITDA. No investor-day targets were found.
Products & Services
The company does not publish SKU-level pricing. The catalogue below is built from the company's descriptors, CARE Ratings rationales (2018, 2019, 2022, 2026) and corporate-history records. Launch years are given where documented.
Brands: Specific trademarked brand names for AYM product lines were not verifiable in the sources reviewed and are treated as not publicly disclosed.
Product Portfolio
| # | Product line | Description / capabilities | Target customer | Launch / latest documented | Pricing model |
|---|---|---|---|---|---|
| 1 | Polyester Textured Yarn (PTY / DTY) | Draw-textured polyester filament yarn; base of the original Silvassa business; texturising capacity ~12,542 MTPA historically | Weavers, knitters (apparel, home textiles) | 1988 (Silvassa); expanded 1990s–2010s | Spread over chip/POY cost; not disclosed |
| 2 | Package-dyed / dope-dyed polyester yarn | Colour-integrated yarns (dope-dyed in melt; package-dyed post-spinning); reduces downstream dyeing | Apparel, upholstery, technical | Documented by CARE 2018 | Premium to grey yarn; not disclosed |
| 3 | High-bulk polyester yarn | Bulked yarns for knitwear, upholstery | Knitters, furnishing makers | Documented by CARE 2018 | — |
| 4 | Speciality Polyester Filament Yarn (Rakholi) | Specialty PFY project at Rakholi, Silvassa | Specialty fabric makers | 1990s | — |
| 5 | Industrial Dyed/Drawn Yarn (IDY) | Higher-tenacity yarns for industrial/technical uses; IDY capacity expansion part of ₹100 cr capex programme (FY2025–FY2026) | Technical-textile converters | Expansion under way FY2025–FY2026 | — |
| 6 | Nylon filament yarn (textured) | Nylon-6 textured yarns; company described by CARE as having strong positioning in Indian nylon yarn market | Hosiery, intimate wear, sportswear, narrow fabrics | Nylon mother-yarn spinning expanded Dec 2013 & May 2016 | — |
| 7 | Nylon mono yarn | Monofilament nylon (Mono Tex machines added at Rakholi/Palghar) | Technical, narrow fabrics | Documented by CARE 2018 | — |
| 8 | Spandex-covered yarn | Nylon/polyester covered elastane yarns for stretch fabrics | Intimate wear, sportswear, medical textiles | Documented by CARE 2018 | — |
| 9 | Nylon mother yarn (captive) | Spun nylon feeder yarn for texturising/BCF | Captive | Expanded 2013, 2016 | Captive |
| 10 | BCF yarn — solid colour | Bulk continuous filament for tufted carpets; leadership position in Indian BCF market (CARE 2018) | Domestic & export carpet/rug mills | Launched Dec 2013 | — |
| 11 | BCF yarn — tri-colour / bi-colour (space-dyed effects) | Higher-margin multi-colour BCF; CARE (Oct 2019) expected contribution from H2 FY2020 | Export carpet/rug mills | FY2020 | Premium BCF |
| 12 | Cabled & heat-set BCF | Twisted/cabled and heat-set BCF for cut-pile carpets (3 cabling machines + heat-setting, Sep 2016) | Carpet mills (cut-pile, plush) | Sep 2016 | — |
| 13 | Polypropylene yarn | PP BCF/filament (Trendlyne profile mentions polypropylene) | Floor coverings, technical | Not dated | — |
| 14 | Sewing thread | Sewing-thread line commissioned in FY2019–FY2020 expansion | Thread converters, garmenters | FY2020 | — |
| 15 | Functional yarns (FR, UV-resistant, antimicrobial) | Engineered yarns with specific functional additives | Technical, automotive, contract, healthcare textiles | Ongoing | — |
| 16 | Recycled / sustainable yarns | Not publicly disclosed in sources reviewed whether AYM has a branded recycled range | — | — | — |
“—” = not publicly disclosed.
Financial Narrative
Basis: consolidated where available (consolidated ≈ standalone). Sources: Arihant Capital/ACE Equity P&L (FY2021–FY2025), IIFL annual results (FY2023–FY2025), Business Standard/Capital Market (FY2026), MarketsMojo (FY2026), financialfilings.com (FY2026 balance sheet and CFO, citing the audit report filed 19 May 2026), Equitymaster, Stockopedia.
Income statement
Notes: FY2026 depreciation derived as PBDT (₹71.31 cr) − PBT (₹9.62 cr). FY2026 tax derived as PBT − NP. FY2022 EBITDA excl. OI derived as PBIDT − other income. FY2022 net profit in Arihant data is ₹50.81 cr vs Equitymaster/Stockopedia ₹50.8 cr (consistent). Note that the FY2022 PBT (₹79.57 cr) less tax (₹14.04 cr) does not reconcile to ₹50.81 cr; the gap likely reflects deferred tax not captured in the "Tax" line of the aggregator table — flagged as an aggregator discrepancy. EPS figures are approximations; company-reported basic/diluted EPS should be taken from the annual reports. FY2021 (for CAGR reference): revenue ₹947.41 cr, PBT ₹17.38 cr, net profit ₹14.09 cr.
Margins
Revenue CAGR: FY2021→FY2026 (5-year) ≈ 7.6% (₹947 cr → ₹1,365 cr; derived). FY2022→FY2026 (4-year) ≈ −2.2% (derived). Screener reports 5-year sales growth of ~7.6–7.7%.
Commentary. The five-year record shows one exceptional year (FY2022, post-COVID restocking: revenue +58%, net profit ₹50.8 cr) followed by a prolonged compression. FY2023–FY2024 saw cheap Chinese yarn imports, weak global textile demand and volatile crude-linked inputs, pushing EBITDA margins below 7.5% and net profit to near zero. FY2025 recovered (revenue +9.6%, EBITDA margin ~8.1% per CARE) on better product mix, softer raw-material costs and higher utilisation. FY2026 reversed again: H1 was loss-making (H1 PBT −₹6.11 cr) because of a demand slowdown, pricing pressure and US reciprocal-tariff disruption to exports; India Ratings estimates ~₹25 cr of additional tariffs were incurred. Q4 FY2026 (net profit ₹9.02 cr) and Q1 FY2027 (₹8.66 cr) mark a clear inflection, with EBITDA margins recovering to ~9%.
Quarterly trajectory (last five quarters)
Sources: Fyers, Business Standard, Groww, Sahi. Q1 FY2027 PBT benefited from a low tax charge (₹0.90 cr) reflecting deferred-tax credit.
Balance sheet
Notes: FY2026 total assets (INR 10.72 bn) and equity (INR 5.89 bn) from financialfilings.com citing the audit report filed 19 May 2026. FY2025 total debt ~₹340 cr per Whalesbook summary of filings. FY2025 equity derived from book value per share × shares. Cash & equivalents, short/long debt split, goodwill and working capital were not verifiable from sources reviewed; goodwill/intangibles are believed negligible (tangible book value per share equals book value per share per StockAlarm). Stockalarm's per-share data implies cash of roughly ₹15 cr and interest-bearing debt of roughly ₹220 cr (TTM basis), but these are aggregator figures and are not tabulated as verified.
Commentary. The October 2024 preferential issue (₹141.76 cr at ₹182.50) materially strengthened the balance sheet: ₹24 cr was earmarked for repayment of borrowings, ₹25 cr for working capital, ₹59 cr for capex and ₹33.76 cr for general corporate purposes, all fully utilised by Q3 FY2026 with no deviations (monitoring agency reports, CARE). Screener flags "company has reduced debt." Leverage is moderate in absolute terms (total debt below ₹1,000 cr; AYM is not a SEBI "Large Corporate") but interest coverage remains thin.
Cash flow
Sources: Indexgaze summary of FY2025 cash flow; financialfilings.com (FY2026 CFO INR 1.51 bn); Screener (net cash flow series). Equitymaster records net cash flow of ₹5.3 cr in FY2021 and ₹5.2 cr in FY2023, consistent with Screener.
Ratios
Sources: Screener (ROE/ROCE snapshots); CARE (working-capital cycle FY2025); derived ratios as labelled. ROIC per StockAlarm TTM ≈ 2.7% (aggregator). 3-year average ROE per Screener ~1.7–1.9%.
Commentary. Returns are structurally weak: ROE has been in low single digits since FY2023, well below the cost of equity, because depreciation and interest absorb ~90% of EBITDA. The key lever is EBITDA margin: each 1 percentage point of margin on ~₹1,400 cr of revenue adds ~₹14 cr to PBT — roughly doubling FY2026 profit. Interest coverage of ~2.4–2.9x (Screener flags "low interest coverage") limits the capacity to absorb another downturn.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products |
|---|---|---|
Synthetic Yarn (sole segment) | All manufacturing and trading of man-made filament yarns | Polyester filament yarn (textured, dyed, dope-dyed, high-bulk, IDY), nylon filament yarn (textured, mono, spandex-covered), BCF yarn (nylon, polyester, PP; solid, tri-/bi-colour, cabled & heat-set), sewing threads, industrial yarns |
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Segment revenue (INR Cr) | 1,358.16 | 1,489.00 | 1,365.12 |
YoY growth (%) | -6.8 | 9.6 | -8.3 |
Segment EBITDA excl. other income (INR Cr) | 101 | 118 | 92.8 |
Segment EBITDA margin (%) | 7.4 | 7.9 | 6.8 |
Profit before tax (INR Cr) | 1.33 | 19.37 | 9.62 |
PBT margin (%) | 0.1 | 1.3 | 0.7 |
Contribution to total revenue (%) | 100 | 100 | 100 |
Group Entities
| Entity | Relationship | Jurisdiction | Function |
|---|---|---|---|
Mandawewala Enterprises Limited | Promoter holding company (62.54%); being amalgamated into AYM | India | Holding company |
AYM Syntex Limited | Listed operating company | India | Manufacturing & export |
AYM Textiles Private Limited | Subsidiary | India | Vehicle for PLI-linked project (CARE Oct 2022 referenced debt-funded PLI capex under subsidiary); operations not material to consolidated numbers |
Innovative Yarns LLC | 100% subsidiary (incorporated 9 Sep 2025) | Delaware, USA | Trading of textile yarns in the US market |
Income Statement and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations | 1,491.46 | 1,457.78 | 1,358.16 | 1,489.00 | 1,365.12 |
Other income | 4.36 | 7.87 | 6.92 | 6.01 | — |
Raw material cost | 878.63 | 873.97 | 746.93 | 822.91 | — |
Gross profit (revenue − raw materials, derived) | 612.83 | 583.81 | 611.23 | 666.09 | — |
Power & fuel | 89.73 | 103.75 | 105.88 | 115.38 | — |
Employee cost | 62.59 | 63.25 | 73.63 | 84.20 | — |
EBITDA excl. other income | 162 | 96 | 101 | 118 | 92.8 |
EBITDA incl. other income (PBIDT) | 166.07 | 103.14 | 101.25 | 124.14 | — |
Interest | — | 35.99 | 42.03 | 42.77 | — |
Depreciation | — | 56.52 | 57.91 | 62.01 | 61.69 |
Profit before tax | 79.57 | 10.63 | 1.33 | 19.37 | 9.62 |
Tax (current + deferred) | 14.04 | 4.36 | 0.22 | 5.27 | 3.07 |
Net profit | 50.81 | 7.17 | 2.04 | 11.63 | 6.55 |
EPS basic (₹, derived on period-end shares) | 10.1 | 1.42 | 0.40 | 1.99 | 1.12 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin (%)
| Margin (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (derived, revenue − ZAR Mn) | 41.1 | 40.0 | 45.0 | 44.7 | — |
EBITDA margin excl. OI | 10.9 | 6.6 | 7.4 | 7.9 | 6.8 |
PBT margin | 5.3 | 0.7 | 0.1 | 1.3 | 0.7 |
Net margin | 3.4 | 0.5 | 0.2 | 0.8 | 0.5 |
Income Statement
| Metric (INR Cr) | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 |
|---|---|---|---|---|---|
Revenue | 326.48 | 349.15 | 323.72 | 365.77 | 351.03 |
EBITDA excl. OI | 19 | 24 | 25 | 33.31 | 31.43 |
Interest | 8 | 8 | 8 | 8 | 8.20 |
PBT | -6 | -0.56 | 2 | 13.43 | 9.56 |
Net profit | -3.56 | -0.39 | 1.48 | 9.02 | 8.66 |
Balance Sheet and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets | — | — | — | — | 1,072 |
Net block (fixed assets) | 458.98 | 448.02 | 480.12 | 482.22 | — |
Total equity | — | — | — | 578 | 589 |
Book value per share (INR) | — | — | — | 98.8 | 100.5 |
Total debt | — | — | — | 340 | — |
Paid-up shares (crore) | 5.03 | 5.04 | 5.06 | 5.85 | 5.86 |
Cash Flow
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow | — | — | — | 108 | 151 |
Investing cash flow | — | — | — | -68 | — |
Net cash flow | -3 | 5 | -2 | 11 | -13 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Buybacks | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
ROE (%) | — | — | 2.3 | 1.1 |
ROCE (%) | — | 6.6 | 8.1 | 5.4 |
Interest coverage (EBITDA/interest, x, derived) | 2.9 | 2.4 | 2.9 | — |
Debt/equity (x, derived) | — | — | 0.59 | — |
Net-debt/EBITDA (x, derived, approx.) | — | — | 2.8 | — |
Asset turnover (x, derived) | — | — | — | 1.27 |
Working-capital cycle (days) | — | — | 37 | — |
Revenue by Region and Revenue by Region (%)
| Metric | FY2022 | FY2024 | FY2025 |
|---|---|---|---|
Export revenue (INR Cr) | 656 | 644.64 | 640.15 |
Export share of revenue (%) | 44 | 47.5 | 43 |
Domestic revenue (INR Cr, derived) | 835 | 713.52 | 848.85 |
Share Price & Returns
| Period | Return (%) | Source |
|---|---|---|
1 month (to 7 Oct 2026) | -11.9 | Business Standard |
3 months | 14.5 | Business Standard |
12 months | 46.6 | Business Standard |
3 years | 305.4 | Business Standard |
5-year CAGR (to Aug 2026) | 23.7 | IIFL |
Metric | Value | — |
Last verified close | ₹273.00 (9 Oct 2026, BSE) | — |
52-week high / low | ₹330.00 / ₹141.53 | — |
Gain from 52-week low | ~100% (Trendlyne, 6 Oct 2026) | — |
Valuation Multiples
| Multiple | AYM Syntex | Filatex India (reference) |
|---|---|---|
P/E (trailing, x) | ~90–100 | ~17.8 |
P/B (x) | ~2.7–2.9 | — |
EV/EBITDA (x) | ~13.4 | ~6.1 |
EV/Sales (x) | ~1.2 | — |
Market cap (INR Cr) | ~1,605 | ~3,257–3,408 |
Credit Ratings
| Agency | Instrument | Amount (INR Cr) | Rating | Date |
|---|---|---|---|---|
CARE Ratings | Long-term bank facilities | 178.40 | CARE A; Stable | Mar 2026 |
CARE Ratings | Short-term bank facilities | 385.00 | CARE A1 | Mar 2026 |
India Ratings | Bank loan facilities | Not captured | IND A; Stable (affirmed) | 2026 |
Moody's / S&P / Fitch | — | — | Not rated | — |
Analyst Conclusions
Guidance and expectations
Management issues no formal guidance. India Ratings expects FY2027 revenue and EBITDA to improve on a richer product mix and normalised US trade, plus recovery of ~₹25 cr of tariff costs. Q1 FY2027 results (revenue +7.5% YoY; EBITDA margin ~9%) are consistent with that view.
Bull case
-
Operating leverage is real: Q4 FY2026 and Q1 FY2027 delivered ~₹9 cr quarterly PAT each; annualised, that exceeds every year since FY2022 and implies FY2027 PAT could be several times FY2026's ₹6.55 cr.
-
Mix upgrade funded: ₹100 cr IDY/BCF capacity, ₹59 cr of it equity-funded, adds higher-margin volume without stretching leverage.
-
Cleaner structure and stronger balance sheet: the post-merger direct promoter holding plus the ₹141.76 cr equity raise lower financial risk and could unlock institutional interest (currently <5%).
Bear case
-
Valuation already discounts recovery: at ~94x trailing earnings and ~13x EV/EBITDA — more than double Filatex's ~6x despite lower margins — the stock leaves little room for disappointment.
-
Structural return deficit: ROE has been ≤2.3% for four years; depreciation and interest absorb ~90% of EBITDA, and the business has never compounded book value meaningfully.
-
External volatility: tariffs, Chinese dumping and crude-linked inputs have repeatedly erased gains (FY2023, FY2024, H1 FY2026), and nothing in the model structurally protects against a repeat.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing |
|---|---|
| Q2 FY2027 results (quarter ending 30 Sep 2026) | Late Oct – mid Nov 2026 |
| NCLT final sanction of Mandawewala Enterprises amalgamation | Pending; FY2027 |
| Recovery of ~₹25 cr tariff costs | FY2027 |
| Commissioning/ramp-up of IDY and BCF capacity | FY2027 |
| US subsidiary revenue contribution | FY2027 |
| Crude/PTA/caprolactam price trend and Chinese export pricing | Continuous |
| Rating actions (CARE/Ind-Ra annual reviews) | Q4 FY2027 |
| Dividend policy initiation | Watch at FY2027 results |
Analyst verdict
AYM Syntex is a credible specialty-yarn franchise trapped in a commodity cost structure. Its genuine differentiators — leadership in Indian BCF carpet yarns, a broad portfolio of dyed and functional nylon and polyester yarns, a 43% export mix spread across demanding markets, and a customer base with no single buyer above 10% — have kept it investment-grade (CARE A/IND A) through repeated downturns. Yet five years of data show a business that converts ₹90–165 cr of EBITDA into only ₹2–51 cr of net profit, because ~₹60 cr of depreciation and ~₹35–43 cr of interest consume most of its operating earnings. The result is chronically low returns: ROE has not exceeded ~2.3% since FY2022.
The near-term picture has turned decisively better. The October 2024 equity raise de-risked the balance sheet; US tariff disruption, which pushed H1 FY2026 into losses, has eased; and the last two quarters each produced ~₹9 cr of PAT on ~9% EBITDA margins. The ₹100 cr IDY/BCF expansion and the US trading subsidiary give the company tangible levers for mix and growth, and the pending reverse merger will simplify its ownership.
The market has noticed: the stock has roughly doubled from its 52-week low and trades at ~94x trailing earnings and ~13x EV/EBITDA, a substantial premium to the larger, more profitable, integrated Filatex India. At these levels, the investment case requires sustained 9%+ EBITDA margins, successful ramp-up of new capacity and no fresh trade shock — a demanding combination for a business with AYM's history of volatility. Our synthesis: operationally improving, financially sound, but fully valued. The key proof points over the next 12 months are whether quarterly PAT holds at ₹8–10 cr through H2 FY2027, whether tariff-cost recovery materialises, and whether management begins returning capital — none of which is yet assured.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / notes | Background |
|---|---|---|---|
Rajesh R. Mandawewala | Chairman, Non-Executive Director (promoter) | Long-standing; co-founder of the Welspun group | Promoter; father of Abhishek Mandawewala |
Abhishek R. Mandawewala | Managing Director & CEO | MD & CEO since 6 May 2017; reappointed 1 Aug 2024 – 31 Jul 2027; earlier Whole-Time Director of Welspun Syntex | Promoter family; age 38 per Simply Wall St |
Khushboo Mandawewala | Whole-Time Director | Retired by rotation and reappointed at 2025 AGM | Spouse of Abhishek Mandawewala |
Yash Mandawewala | Director (listed by Simply Wall St) | — | Promoter family |
Sudhanshu Khire | Director – Operations | Resigned effective 31 May 2026 | — |
Vineet Adlakha | President & Unit Head (Palghar) | Appointed 2025-26 | — |
Directors' Remuneration
| Executive | FY | Salary share | Total compensation |
|---|---|---|---|
Abhishek Mandawewala (MD & CEO) | FY2025 | 85.5% fixed salary | ₹2.59 cr (₹25,892,739) |
Abhishek Mandawewala (MD & CEO) | FY2024 | — | ~₹2.1 cr |
Board & Management Changes
| Date | Change |
|---|---|
30 May 2024 | MD & CEO reappointed for 3 years from 1 Aug 2024 |
Jul–Sep 2024 | Director changes during FY2025 (appointments 8–9 Jul 2024; one resignation effective 23 Sep 2024; further change 14 Nov 2024 per Directors' Report) — names not captured in sources |
1 Jul 2025 | Change in management disclosed (details not captured) |
FY2026 | Vineet Adlakha appointed President & Unit Head (Palghar) |
31 May 2026 | Sudhanshu Khire resigned as Director – Operations |
Major Shareholders
| Holder | Category | Stake 30 Jun 2026 (%) |
|---|---|---|
Mandawewala Enterprises Limited | Promoter | 62.54 |
Other promoter-group entities | Promoter | 3.19 |
Mukul Mahavir Agrawal | Public (individual investor) | 3.92 |
MGN Agro Properties Private Limited | Public | 2.76 |
Sadhna Mehrotra | Public | 2.17 |
Nisarg Vakharia | Public | 1.91 |
FIIs (aggregate) | Institutional | 3.62 |
DIIs (aggregate) | Institutional | 0.48 |
Mutual funds | Institutional | 0.00 |
Holding (%) | Q1 FY2026 | Q2 FY2026 |
Promoters | 65.90 | 65.90 |
FIIs | 3.81 | 3.28 |
DIIs | 0.02 | 0.41 |
Others / public | 30.27 | 30.41 |
Competitive Landscape
Competitors by Segment
| Product area | Competitors (India & global) |
|---|---|
Polyester filament yarn (POY/FDY/DTY) | Reliance Industries (polyester division), Filatex India, Indo Rama Synthetics, Sanathan Textiles, Wellknown Polyesters, Sumeet Industries, Garden Silk Mills, Chinese exporters (Hengli, Tongkun, Xin Fengming) |
Nylon filament yarn | Century Enka, Gujarat-based nylon spinners, Chinese and Taiwanese nylon producers |
BCF yarn (carpets) | Aquafil (Italy), Universal Fibers (US), Beaulieu Fibres International (Belgium), captive BCF of global carpet majors (e.g., Shaw Industries, Mohawk), Indian/Chinese BCF spinners |
Specialty/dyed yarns & threads | Raj Rayon, A&E (sewing thread), Vardhman (threads), Chinese dyed-yarn exporters |
Peer Comparison FY2026
| Company | FY2026 revenue (INR Cr) | FY2026 PAT (INR Cr) | Net margin (%) | Positioning |
|---|---|---|---|---|
AYM Syntex | 1,365 | 6.55 | 0.5 | Specialty/BCF focus, not integrated |
Filatex India | 4,161 | 183.9 | 4.4 | Integrated PFY; ₹690 cr growth capex FY2026–FY2027; FY2027 revenue guidance ₹4,600–4,700 cr |
Sanathan Textiles | — | 77 (annual PAT, Fyers peer table) | — | Polyester, cotton & technical yarns; listed Dec 2024 |
Sumeet Industries | — | — | — | Polyester yarn & chips |



